Navigation Links
Spherix to Raise $1.25 Million in Private Placement
Date:10/26/2011

ducts, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of D-tagatose, the FDA may interpret the results of studies differently than us, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends, our continuing efforts to develop D-tagatose may be unsuccessful, our common stock could be delisted from the Nasdaq Capital Market, and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Spherix Announces Results from New Preclinical Studies Showing SPX-106T Produces Significant Reductions in Cholesterol, Fat Deposition and Body Weight
2. Spherix Announces Annual Shareholders Meeting Date
3. Spherix to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
4. Spherix Regains Compliance With NASDAQ Listing Rule
5. Spherix Announces First Quarter Financial Results
6. Spherix Announces Reverse Stock Split Effective May 6, 2011
7. Spherix to Effect Reverse Stock Split
8. Spherix Announces 2010 Financial Results
9. Spherix to Present at the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference
10. Spherix to Present at the 13th Annual BIO CEO & Investor Conference
11. Spherix Announces Closing of Registered Direct Offering of $2.77 Million in Common Stock and Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 The Workgroup for Electronic Data ... use of health IT to create efficiencies in healthcare ... (HPID) Workgroup has developed an issue brief titled, ... Payer?” The HPID Workgroup, a part of WEDI’s Strategic ... for Medicare and Medicaid Services (CMS) to identify common ...
(Date:7/28/2014)... -- Research and Markets has announced the ... report to their offering. ... covers the designing and engineering of completely new biological ... of natural biological systems that provide improved and desirable ... extreme genetic engineering because it not only alters existing ...
(Date:7/28/2014)... 2014 Immunomic Therapeutics, Inc. (ITI) has ... develop potential treatments for glioblastoma multiforme (GBM), the most ... their patented vaccine platform, LAMP-vax. , The agreements, ... on the work of John H. Sampson, MD, PhD, ... Robert Tisch Brain Tumor Center at Duke University Medical ...
(Date:7/28/2014)... California (PRWEB) July 28, 2014 The ... 604.40 billion by 2020, according to a new study ... with the rising demand for effective vaccines and drugs ... with unmet medical needs is expected to drive market ... need to enhance agricultural productivity via the use of ...
Breaking Biology Technology:WEDI’s HPID Workgroup Announces Release of Issue Brief: “What is the Difference Between a Health Plan and Payer?” 2Global Synthetic Biology Market 2014-2018 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4
... Scientists have discovered the world,s smallest superconductor, a ... nanometer wide. The Ohio University-led study, published Sunday as ... Nanotechnology , provides the first evidence that nanoscale molecular ... for nanoscale electronic devices and energy applications. "Researchers ...
... may revolutionize how and when physicians diagnose Alzheimer,s disease. ... The FASEB Journal ( http://www.fasebj.org ), the new ... be one of the main causes of brain degeneration ... A-Beta oligomers. This tool, once fully implemented, would ...
... ... Service, the global leader in chemical information and a division of the American ... pathways and improve productivity for researchers working in the chemical, pharmaceutical, biotechnology, and ... in every aspect of the chemical R&D process. , ...
Cached Biology Technology:Scientists discover world's smallest superconductor 2New test takes guesswork out of diagnosing early stage Alzheimer's disease 2New SciFinder Features Reveal More Synthetic Pathways and Improve Productivity 2New SciFinder Features Reveal More Synthetic Pathways and Improve Productivity 3
(Date:7/28/2014)... himself the bug hunter, but the target of his ... and identified with special methods and instruments. Benjamin Hause, ... Diagnostic Laboratory at Kansas State University, recently published an ... which is an important find in the United States. ... didn,t know what it was," Hause said. "We used ...
(Date:7/28/2014)... Research and Markets has announced the addition ... report to their offering. ... biological data. These systems capture biological traits such as ... hand measurements from the subject and compare the data ... of a biometrics system is to identify and verify ...
(Date:7/28/2014)... Norwegian explorer Roald Amundsen became the first man ... More than 100 years later, an international team of ... Institute (DRI) have proven that air pollution from industrial ... ice cores collected from widely spaced locations around the ... the most accurate and precise reconstruction to date of ...
Breaking Biology News(10 mins):Researcher using next-generation sequencing to rapidly identify pathogens 2Researcher using next-generation sequencing to rapidly identify pathogens 3Biometrics Market in Latin America 2014-2018 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 3
... pulmonary fibrosis (IPF) is a chronic and progressive lung disorder ... The disease is characterized by the insidious onset of dyspnea ... , Now, Selman and coworkers present in an article published ... May, strong evidence indicating that a subset of IPF patients ...
... at the first signs of cold weather. Rather, new research ... survive the chilly months. , These so-called "heat-shock proteins" ensure ... spring. , A study of flesh flies and a ... of protective heat-shock proteins that are turned on almost as ...
... for revealing anatomical details of soft tissues. Contrast agents ... allow physiological processes to be followed in real time. ... cannot reveal anatomic structures. As reported in the journal ... at Samsung Medical Center and Taeghwan Hyeon at Seoul ...
Cached Biology News:Extra-aggressive form of idiopathic pulmonary fibrosis identified 2For many insects, winter survival is in the genes 2For many insects, winter survival is in the genes 3
...
... Johnstone and M.W. Turner (1997). • ... methods used in the production of ... in immunoassays, the standardisation of antibodies ... including amplification systems, enzyme immunoassays for ...
... The 1-D PAGE ... Kit for Targeted Protein ... SDS PolyAcrylamide Gel Electrophoresis ... chemistry, and cleavable-linker technology ...
Thermal Printer Paper for Monolight(tm) Luminometer 1 each...
Biology Products: